{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:52:12Z","timestamp":1789253532934,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82000169"],"award-info":[{"award-number":["NSFC82000169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007055","name":"Third Military Medical University","doi-asserted-by":"publisher","award":["2021XJS15"],"award-info":[{"award-number":["2021XJS15"]}],"id":[{"id":"10.13039\/501100007055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011476","name":"Southwest Hospital","doi-asserted-by":"publisher","award":["AWS17J007"],"award-info":[{"award-number":["AWS17J007"]}],"id":[{"id":"10.13039\/501100011476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011476","name":"Southwest Hospital","doi-asserted-by":"publisher","award":["2022DZXDX004"],"award-info":[{"award-number":["2022DZXDX004"]}],"id":[{"id":"10.13039\/501100011476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["cstc2020jcyj-msxmX1058"],"award-info":[{"award-number":["cstc2020jcyj-msxmX1058"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jtct.2024.07.017","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T13:55:17Z","timestamp":1722261317000},"page":"32.e1-32.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Chengxin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangnian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jtct.2024.07.017_bib0001","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"The Lancet Haematology"},{"issue":"3","key":"10.1016\/j.jtct.2024.07.017_bib0002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood-2014-02-514760","article-title":"Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist","volume":"124","author":"Kekre","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2024.07.017_bib0003","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3324\/haematol.2018.189258","volume":"103","author":"Salvatore","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jtct.2024.07.017_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-021-01065-7","volume":"14","author":"Nagler","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2024.07.017_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.jtct.2024.07.017_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101080","article-title":"Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies","author":"Dul\u00e9ry","year":"2023","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.jtct.2024.07.017_bib0007","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41409-020-0792-x","article-title":"Rabbit ATG\/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel","volume":"55","author":"Bonifazi","year":"2020","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2024.07.017_bib0008","article-title":"Haploidentical transplants with a G-CSF\/ATG-based protocol: experience from China","author":"Xu","year":"2022","journal-title":"Blood Rev"},{"issue":"25","key":"10.1016\/j.jtct.2024.07.017_bib0009","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2024.07.017_bib0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3324\/haematol.2016.151779","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant","volume":"102","author":"Ruggeri","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jtct.2024.07.017_bib0011","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ajh.25087","article-title":"Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study","volume":"93","author":"Li","year":"2018","journal-title":"American Journal of Hematology"},{"issue":"26","key":"10.1016\/j.jtct.2024.07.017_bib0012","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","article-title":"Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete haploidentical donor transplantation using post-transplant cyclophosphamide","volume":"35","author":"Bashey","year":"2017","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"7","key":"10.1016\/j.jtct.2024.07.017_bib0013","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cncr.31228","article-title":"Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide","volume":"124","author":"Ruggeri","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2024.07.017_bib0014","article-title":"Combining PTCy and ATG for GvHD prophylaxis in non-malignant diseases","author":"DeZern","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2024.07.017_bib0015","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.jtct.2024.07.017_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.jtct.2024.07.017_bib0017","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017)","author":"Higgins","year":"2017"},{"key":"10.1016\/j.jtct.2024.07.017_bib0018","unstructured":"Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2021. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed November 15, 2021."},{"key":"10.1016\/j.jtct.2024.07.017_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.921293","article-title":"Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia","volume":"13","author":"Barkhordar","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.jtct.2024.07.017_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.retram.2022.103360","volume":"71","author":"Cao","year":"2023","journal-title":"Current Research in Translational Medicine"},{"issue":"1","key":"10.1016\/j.jtct.2024.07.017_bib0021","article-title":"Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia","volume":"28","author":"Cao","year":"2023","journal-title":"Hematology (United Kingdom)"},{"key":"10.1016\/j.jtct.2024.07.017_bib0022","first-page":"31","article-title":"Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as an effective regimen for prophylaxis of graft versus host disease after haploidentical peripheral blood stem cell transplantation with maternal\/collateral related donors","author":"Li","year":"2022","journal-title":"Cell Transplantation"},{"issue":"11","key":"10.1016\/j.jtct.2024.07.017_bib0023","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356152","article-title":"Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF\/ATG induced GVHD protective activity and improve haploidentical transplant outcomes","volume":"6","author":"Wang","year":"2017","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.jtct.2024.07.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0781-y","article-title":"Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients","volume":"12","author":"Wang","year":"2019","journal-title":"Journal of Hematology and Oncology"},{"issue":"3","key":"10.1016\/j.jtct.2024.07.017_bib0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41409-020-01047-2","volume":"56","author":"Xu","year":"2021","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1016\/j.jtct.2024.07.017_bib0026","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bjh.18483","volume":"200","author":"Zhang","year":"2023","journal-title":"British Journal of Haematology"},{"issue":"9","key":"10.1016\/j.jtct.2024.07.017_bib0027","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jtct.2022.06.006","volume":"28","author":"Battipaglia","year":"2022","journal-title":"Transplantation and Cellular Therapy"},{"issue":"4","key":"10.1016\/j.jtct.2024.07.017_bib0028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12185-021-03280-x","article-title":"Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies","volume":"115","author":"Chen","year":"2022","journal-title":"International Journal of Hematology"},{"issue":"4","key":"10.1016\/j.jtct.2024.07.017_bib0029","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/0284186X.2020.1837947","article-title":"Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide","volume":"60","author":"Chevallier","year":"2021","journal-title":"Acta Oncologica"},{"issue":"5","key":"10.1016\/j.jtct.2024.07.017_bib0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4049\/jimmunol.2000578","article-title":"Posttransplant cyclophosphamide and antithymocyte globulin versus posttransplant cyclophosphamide as graft-versus-host disease prophylaxis for peripheral blood stem cell haploidentical transplants: comparison of T cell and NK effector reconstitution","volume":"205","author":"Makanga","year":"2020","journal-title":"Journal of Immunology"},{"issue":"22","key":"10.1016\/j.jtct.2024.07.017_bib0031","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.5871.5871","article-title":"Addition of ATG to myeloablative haplo conditioning with post-transplantation cyclophosphamide might decrease the risk of GvHD and TRM without increasing the risk of relapse","volume":"128","author":"Dawsari","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2024.07.017_bib0032","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clml.2020.04.003","article-title":"Impact of adding antithymocyte globulin to posttransplantation cyclophosphamide in haploidentical stem-cell transplantation","volume":"20","author":"El-Cheikh","year":"2020","journal-title":"Clinical Lymphoma, Myeloma and Leukemia"},{"issue":"6","key":"10.1016\/j.jtct.2024.07.017_bib0033","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41409-023-01956-y","article-title":"Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival","volume":"58","author":"Jullien","year":"2023","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1016\/j.jtct.2024.07.017_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041097","article-title":"Outcomes of different haploidentical transplantation strategies from the Taiwan Blood and Marrow Transplantation Registry","volume":"14","author":"Tsai","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.jtct.2024.07.017_bib0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbmt.2018.01.005","article-title":"Sequential conditioning with thiotepa in T cell- replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with matched related, haplo-mismatched, and unrelated donors","volume":"24","author":"Dul\u00e9ry","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2024.07.017_bib0036","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41409-018-0382-3","volume":"54","author":"Yang","year":"2019","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1016\/j.jtct.2024.07.017_bib0037","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41409-022-01908-y","article-title":"Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1016\/j.jtct.2024.07.017_bib0038","first-page":"428","article-title":"Experience using anti-thymocyte globulin with post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis in peripheral blood haploidentical stem cell transplantation","volume":"27","author":"Salas","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2024.07.017_bib0039","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3324\/haematol.2020.271445","article-title":"Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation","volume":"107","author":"Massoud","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2024.07.017_bib0040","first-page":"482","article-title":"Comparison of the impact of ATG\/PT-CY-based and TCR \u03b1\u03b2-depletion as GVHD prophylaxis regimens on the recovery of memory T-cell compartment","volume":"54","author":"Popova","year":"2019","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2024.07.017_bib0041","first-page":"335","article-title":"High-dose cyclophosphamide after allogeneic stem cell transplantation influences on reconstitution of memory CD8+ T cell subsets","volume":"53","author":"Popova","year":"2019","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1016\/j.jtct.2024.07.017_bib0042","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/bloodadvances.2021005509","article-title":"Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG","volume":"6","author":"Turki","year":"2021","journal-title":"Blood Advances"},{"key":"10.1016\/j.jtct.2024.07.017_bib0043","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1097\/01.HS9.0000848200.25194.d9","article-title":"The impact of immunosuppression on reconstitution of CMV-specific T cells after allogeneic hematopoietic stem cell transplantation","volume":"6","author":"Dmitrova","year":"2022","journal-title":"HemaSphere"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724005487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724005487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:39:27Z","timestamp":1767238767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724005487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2666636724005487"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.07.017","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}